Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Correlates of Good Vision in Eyes With Subfoveal Scars From Neovascular Age-Related Macular Degeneration.

Meshi A, Camacho N, Lin T, Muftuoglu IK, Arcinue CA, Gaber R, You QS, Freeman WR.

Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 1;49(10):765-774. doi: 10.3928/23258160-20181002-04.

PMID:
30395662
2.

Reply.

Muftuoglu IK, Arcinue CA, Tsai FF, Alam M, Gaber R, Camacho N, Freeman WR.

Am J Ophthalmol. 2017 Jan;173:146. doi: 10.1016/j.ajo.2016.09.023. Epub 2016 Nov 11. No abstract available.

PMID:
27842697
3.

Reply.

Muftuoglu IK, Arcinue CA, Alam M, Gaber R, Camacho N, You Q, Tsai FF, Freeman WR.

Am J Ophthalmol. 2016 Oct;170:247-248. doi: 10.1016/j.ajo.2016.08.001. Epub 2016 Sep 16. No abstract available.

PMID:
27646165
4.

Long-Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Persistent Neovascular Age-Related Macular Degeneration.

Muftuoglu IK, Arcinue CA, Tsai FF, Alam M, Gaber R, Camacho N, You Q, Freeman WR.

Am J Ophthalmol. 2016 Jul;167:1-9. doi: 10.1016/j.ajo.2016.03.038. Epub 2016 Apr 2.

PMID:
27049000
5.

RECALCITRANT CYSTOID MACULAR EDEMA AFTER PARS PLANA VITRECTOMY.

Alam MR, Arcinue CA, Mendoza NB, Freeman WR.

Retina. 2016 Jul;36(7):1244-51. doi: 10.1097/IAE.0000000000000892.

PMID:
26655611
6.

ANALYSIS OF A CONFOCAL SCANNING LASER OPHTHALMOSCOPE NONCONTACT ULTRA-WIDE FIELD LENS SYSTEM IN RETINAL AND CHOROIDAL DISEASE.

Espina MP, Arcinue CA, Ma F, Camacho N, Bartsch DU, Freeman WR.

Retina. 2015 Dec;35(12):2664-8. doi: 10.1097/IAE.0000000000000899. No abstract available.

7.

Outer retinal tubulations response to anti-VEGF treatment.

Espina M, Arcinue CA, Ma F, Camacho N, Barteselli G, Mendoza N, Ferrara N, Freeman WR.

Br J Ophthalmol. 2016 Jun;100(6):819-23. doi: 10.1136/bjophthalmol-2015-307141. Epub 2015 Sep 30.

8.

Visual phenomena perceived during pars plana vitrectomy under peribulbar block and monitored anaesthesia care.

Ramkumar HL, Khatibi A, Freeman WR, Barteselli G, Ezon IC, Amini P, Sharpsten L, Arcinue CA, Nezgoda JT, Ferreyra HA, Goldbaum MH.

Br J Ophthalmol. 2016 Jun;100(6):777-81. doi: 10.1136/bjophthalmol-2015-306874. Epub 2015 Sep 17.

PMID:
26385093
9.

Retinal Thickening and Photoreceptor Loss in HIV Eyes without Retinitis.

Arcinue CA, Bartsch DU, El-Emam SY, Ma F, Doede A, Sharpsten L, Gomez ML, Freeman WR.

PLoS One. 2015 Aug 5;10(8):e0132996. doi: 10.1371/journal.pone.0132996. eCollection 2015.

10.

Reply: To PMID 25461263.

Arcinue CA, Ma F, Barteselli G, Sharpsten L, Gomez ML, Freeman WR.

Am J Ophthalmol. 2015 May;159(5):997. doi: 10.1016/j.ajo.2015.02.010. No abstract available.

PMID:
25867596
11.

One-year outcomes of aflibercept in recurrent or persistent neovascular age-related macular degeneration.

Arcinue CA, Ma F, Barteselli G, Sharpsten L, Gomez ML, Freeman WR.

Am J Ophthalmol. 2015 Mar;159(3):426-36.e2. doi: 10.1016/j.ajo.2014.11.022. Epub 2014 Nov 18.

12.

Optical coherence tomography findings of the vitreoretinal interface in asymptomatic fellow eyes of patients with acute posterior vitreous detachment.

Ma F, Arcinue CA, Barteselli G, Cheng L, Ezon I, Lee SN, Freeman WR.

Retina. 2014 Mar;34(3):447-54. doi: 10.1097/IAE.0000000000000025.

PMID:
24136409
13.

Diagnostic criteria for primary ocular lymphoma.

Arcinue CA, Hochberg F, Neumann R, Foster CS.

Ophthalmology. 2013 Mar;120(3):646-646.e2. doi: 10.1016/j.ophtha.2012.09.053. No abstract available.

PMID:
23714608
14.

Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease.

Suelves AM, Arcinue CA, González-Martín JM, Kruh JN, Foster CS.

Ophthalmology. 2013 Jun;120(6):1201-9. doi: 10.1016/j.ophtha.2013.01.031. Epub 2013 Apr 16.

PMID:
23601800
15.

Acute unilateral toxoplasma retinochoroiditis associated with adalimumab, a tumor necrosis factor-α antagonist.

Radwan A, Baheti U, Arcinue CA, Hinkle DM.

Retin Cases Brief Rep. 2013 Spring;7(2):152-4. doi: 10.1097/ICB.0b013e3182790dbd.

PMID:
25390810
16.

Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema.

Radwan AE, Arcinue CA, Yang P, Artornsombudh P, Abu Al-Fadl EM, Foster CS.

Graefes Arch Clin Exp Ophthalmol. 2013 Jul;251(7):1801-6. doi: 10.1007/s00417-013-2309-4. Epub 2013 Mar 22.

PMID:
23519884
17.

Comparison of two different combination immunosuppressive therapies in the treatment of Vogt-Koyonagi-Harada syndrome.

Arcinue CA, Radwan A, Lebanan MO, Foster CS.

Ocul Immunol Inflamm. 2013;21(1):47-52. doi: 10.3109/09273948.2012.728668.

PMID:
23323581
18.

A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.

Arcinue CA, Cerón OM, Foster CS.

J Ocul Pharmacol Ther. 2013 Jun;29(5):501-7. doi: 10.1089/jop.2012.0180. Epub 2013 Jan 8.

PMID:
23297752

Supplemental Content

Loading ...
Support Center